Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Gynecol Oncol. 2017 Sep 7;147(2):375–380. doi: 10.1016/j.ygyno.2017.08.030

Table 4.

Ovarian cancer case-case analysis by age at diagnosis.

Gene Cases < 60 at diagnosis (n = 4132) Cases ≥ 60 at diagnosis (n = 3564)



OC cases tested Cases with P/LP % positive OC cases tested Cases with P/LP % positive OR 95% CI p-Value
ATM 3341 34 1.0 2916 19 0.65 1.57 0.87–2.92 0.11
BRCA1 3975 226 5.7 3451 70 2.0 2.91 2.21–3.88 8.90 × 10−16
BRCA2 3975 121 3.0 3451 129 3.7 0.81 0.62–1.05 0.10
BRIP1 3330 19 0.57 2906 42 1.4 0.39 0.21–0.69 0.0005
MSH2 3928 25 0.64 3421 3 0.09 7.3 2.22–37.8 0.0001
MSH6 3928 43 1.1 3421 5 0.15 7.56 3.00–24.5 4.80 × 10−7
NBN 3330 13 0.39 2906 11 0.38 1.05 0.41–2.71 0.91
PALB2 3350 10 0.3 2929 13 0.44 0.67 0.26–1.66 0.34
RAD51C 3330 29 0.87 2906 21 0.72 1.21 0.66–2.23 0.51
RAD51D 3020 5 0.17 2675 13 0.49 0.34 0.09–1.02 0.03